BMO Capital raised the firm’s price target on ManpowerGroup (MAN) to $45 from $44 and keeps an Outperform rating on the shares. The company’s Q4 results slightly beat consensus estimates, aided by the weaker USD, though constant currency growth accelerated modestly, the analyst tells investors in a research note. Enterprise staffing and blue collar assignments are faring well while permanent placement and RPO continue to struggle, the firm added. Published first on TheFly – the ultimate source for real-t ...

Group 1 - Evercore ISI raised the price target on Labcorp (LH) to $305 from $300 while maintaining an Outperform rating on the shares [1] - The firm's survey indicates a positive outlook for preclinical CROs, with rising budgets and declining cancellations [1] - There is stable demand for discovery and toxicology services projected into 2025 and 2026 [1]